PREGICOB-ER-82.5GM

Pregabalin 82.5 mg Extended Release (ER) is a sustained-release formulation designed for the long-term management of neuropathic pain and certain neurological conditions. The extended-release technology ensures gradual release of the active ingredient over 24 hours, providing consistent symptom control, improved patient compliance, and reduced dosing frequency compared to immediate-release formulations.

Pregabalin works by binding to the alpha-2-delta subunit of voltage-gated calcium channels in the central nervous system. This action reduces the release of excitatory neurotransmitters, thereby decreasing nerve signal transmission responsible for chronic pain and seizures.

This formulation is commonly prescribed for:

Diabetic peripheral neuropathy

Post-herpetic neuralgia

Fibromyalgia

Neuropathic pain due to spinal cord injury

Adjunct therapy in partial onset seizures

The extended-release version is particularly beneficial for patients requiring stable, round-the-clock symptom relief.